Our Deals
Deals
Xenometrics acquired by CitoxLab October 31, 2017
Overview
CitoxLab, a leader amongst non-clinical CROs, announced its acquisition of Xenometrics on October 31, 2017.
Xenometrics is a US-based CRO that specializes in the non-clinical assessment of new drug candidates.
Significance
CitoxLab’s acquisition of Xenometrics significantly improves its ability to reach U.S. customers, as it previously had no subsidiary in the U.S.
The acquisition will allow CitoxLab to provide more services and additional capacity to its client portfolio with an increase in study slots.
Crosstree’s Role
Crosstree Capital Partners served as exclusive financial advisor to Xenometrics.
Sub-Sector
Pharma Services
Diagnostics and Tools
Type
Merger and Acquisition
Deal Tags
Pharma Lab Services
Cross-border
Diagnostic Laboratory
International client or transaction